Search
forLearn
5 / 801 resultslearn procapil
learn Hair Multiplication
extract, clone, and reinsert your own hair cells
learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
learn TeraBond™ (Actera)
Research
5 / 1000+ results
research Financial Feasibility of A Hair Care-Based Business
Sassle's haircare business is financially viable and profitable.
research LEVEL OF BENEFIT FROM FINANCIAL LEASING IN SMES IN THE INDUSTRIAL SECTOR
Financial leasing is beneficial for small and medium-sized businesses in the industrial sector.
research 44249 Financing Finasteride: Identifying Resources to Improve Access
GoodRx.com helps find the cheapest options for finasteride, a medication not often covered by insurance.
research The financial burden of alopecia: a survey study
Alopecia treatments are costly and often not covered by insurance, causing financial stress.
research The financial burden of scalp cooling therapy: A nonprofit organization data analysis
Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.
Community Join
5 / 350 resultscommunity Most reliable and financially most advantageous source to get Minoxidil? (NL/EU)
People in the Netherlands are discussing reliable sources to buy Minoxidil, with recommendations for local pharmacies and online pharmacies with NL or neighboring country addresses. Concerns include avoiding fake products, insurance coverage, and the legitimacy of certain online sellers like Foligain and Biovea.
community New company Amplifica gets $11.8 million in financing for development of its hair loss products. Dr. Maksim Plikus and William Rassman are co-founders.
New company Amplifica receives $11.8 million for hair loss product development, co-founded by Dr. Maksim Plikus and William Rassman. Users discuss undisclosed product candidates and application methods.
community How Veradermics secured a total of $220 million in series B and C financing for oral minoxidil, I will never understand.....
Veradermics' oral minoxidil shows promise for hair regrowth, with some users reporting significant improvements, while Pelage's PP405 results are less convincing and lack transparency. There is skepticism about both treatments' long-term effectiveness and potential side effects.
community Why are there no proper phase 3 trials for RU
RU58841 lacks FDA approval due to financial and safety concerns, including potential cardiological side effects. The company abandoned further research, and users report adverse effects like heart palpitations and gynecomastia.
community Disappointing news on Breezula/CB-03-01
The conversation discusses disappointment over only receiving a financial report from Cassiopea instead of trial results for Breezula/CB-03-01, a hair loss treatment. However, there is optimism as the company is advancing Breezula into Phase III trials for men, starting trials for women, and submitting an NDA for their acne product, Winlevi.